# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-019170
Filing Date
2021-08-10
Accepted
2021-08-10 16:05:59
Documents
53
Period of Report
2021-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 1248520
2 |  | ex31-1.htm | EX-31.1 | 11223
3 |  | ex31-2.htm | EX-31.2 | 11243
4 |  | ex32-1.htm | EX-32.1 | 4053
5 |  | ex32-2.htm | EX-32.2 | 4091
| Complete submission text file | 0001493152-21-019170.txt |  | 5650940

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | lixt-20210630.xsd | EX-101.SCH | 43011
7 | XBRL CALCULATION FILE | lixt-20210630_cal.xml | EX-101.CAL | 31685
8 | XBRL DEFINITION FILE | lixt-20210630_def.xml | EX-101.DEF | 214864
9 | XBRL LABEL FILE | lixt-20210630_lab.xml | EX-101.LAB | 353363
10 | XBRL PRESENTATION FILE | lixt-20210630_pre.xml | EX-101.PRE | 265288
11 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 945114

Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39717 | Film No.: 211159897
SIC: 2834 Pharmaceutical Preparations